PharmiWeb.com - Global Pharma News & Resources
14-Jan-2019

NIASPAN Drug Profile, 2019 - Patents, Clinical Trials, Drug Prices, Annual Sales Revenues and Raw API Sources - ResearchAndMarkets.com

The "NIASPAN Drug Profile, 2019" report has been added to ResearchAndMarkets.com's offering.

NIASPAN Drug Profile, 2019 is part of a deep library of business intelligence on biopharmaceutical drugs. The report focuses on NIASPAN and covers the following critical aspects of this drug:

  • United States patents
  • Expired United States patents
  • District Court patent litigation
  • Clinical trials
  • Drug prices
  • Annual sales revenues
  • Finished product suppliers
  • Raw active pharmaceutical ingredient (API) sources

Topics Covered

  • Profile for NIASPAN
  • US Patents
  • Expired US Patents
  • US District Court Litigation
  • International (ex US) Patents
  • Clinical Trials
  • Drug Prices - Average Pharmacy Cost
  • Annual Sales Revenues
  • Finished Product Suppliers
  • Bulk API Sources

Companies Featured

  • Abbvie
  • Rebel Distributors Corp
  • A-S Medication Solutions
  • Carilion Materials Management
  • Dispensing Solutions Inc.
  • Zydus Pharmaceuticals USA Inc
  • Chemexper Chemical Directory
  • Sigma-Aldrich
  • Specs
  • Novoseek
  • Vitas-M Laboratory
  • Mp Biomedicals
  • Emd Biosciences
  • Molport
  • Nih Clinical Collection
  • Abi Chem
  • Finetech Industry Limited
  • Chembase.Cn
  • Nanjing Kaimubo
  • Ak Scientific Inc. (Aksci)
  • Alsachim
  • Debye Scientific Co. Ltd
  • Molepedia
  • Boc Sciences
  • Oxchem Corporation
  • Zinc
  • Alfa Aesar
  • Molmall
  • Ambinter
  • Combi-Blocks
  • Aa Blocks
  • 001Chemical
  • Ambeed
  • Acros Organics
  • and many more...

For more information about this report visit https://www.researchandmarkets.com/research/mqgm5f/niaspan_drug?w=4

View source version on businesswire.com: https://www.businesswire.com/news/home/20190114005397/en/

Editor Details

Last Updated: 14-Jan-2019